Publication Information

{'id': 'https://openalex.org/W2079609061', 'doi': 'https://doi.org/10.1136/bmj.f6989', 'title': 'Majority of panelists on controversial new cholesterol guideline have current or recent ties to drug manufacturers', 'display_name': 'Majority of panelists on controversial new cholesterol guideline have current or recent ties to drug manufacturers', 'publication_year': 2013, 'publication_date': '2013-11-21', 'ids': {'openalex': 'https://openalex.org/W2079609061', 'doi': 'https://doi.org/10.1136/bmj.f6989', 'mag': '2079609061', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/24264770'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1136/bmj.f6989', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4393917726', 'display_name': 'BMJ', 'issn_l': '1756-1833', 'issn': ['1756-1833'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5091736994', 'display_name': 'J. Lenzer', 'orcid': None}, 'institutions': [], 'countries': ['US'], 'is_corresponding': True, 'raw_author_name': 'J. Lenzer', 'raw_affiliation_strings': ['1New York'], 'affiliations': [{'raw_affiliation_string': '1New York', 'institution_ids': []}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 0, 'corresponding_author_ids': ['https://openalex.org/A5091736994'], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 10.558, 'has_fulltext': True, 'fulltext_origin': 'ngrams', 'cited_by_count': 38, 'citation_normalized_percentile': {'value': 0.895145, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 94, 'max': 95}, 'biblio': {'volume': '347', 'issue': 'nov21 5', 'first_page': 'f6989', 'last_page': 'f6989'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11649', 'display_name': 'Pharmaceutical industry and healthcare', 'score': 0.9917, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11649', 'display_name': 'Pharmaceutical industry and healthcare', 'score': 0.9917, 'subfield': {'id': 'https://openalex.org/subfields/3004', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/30', 'display_name': 'Pharmacology, Toxicology and Pharmaceutics'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T12168', 'display_name': 'Health and Medical Research Impacts', 'score': 0.943, 'subfield': {'id': 'https://openalex.org/subfields/2739', 'display_name': 'Public Health, Environmental and Occupational Health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/guideline', 'display_name': 'Guideline', 'score': 0.7629797}], 'concepts': [{'id': 'https://openalex.org/C2780182762', 'wikidata': 'https://www.wikidata.org/wiki/Q1630279', 'display_name': 'Guideline', 'level': 2, 'score': 0.7629797}, {'id': 'https://openalex.org/C2780035454', 'wikidata': 'https://www.wikidata.org/wiki/Q8386', 'display_name': 'Drug', 'level': 2, 'score': 0.53367376}, {'id': 'https://openalex.org/C144133560', 'wikidata': 'https://www.wikidata.org/wiki/Q4830453', 'display_name': 'Business', 'level': 0, 'score': 0.45804283}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.4566142}, {'id': 'https://openalex.org/C98274493', 'wikidata': 'https://www.wikidata.org/wiki/Q128406', 'display_name': 'Pharmacology', 'level': 1, 'score': 0.2585208}, {'id': 'https://openalex.org/C142724271', 'wikidata': 'https://www.wikidata.org/wiki/Q7208', 'display_name': 'Pathology', 'level': 1, 'score': 0.09195909}], 'mesh': [{'descriptor_ui': 'D002318', 'descriptor_name': 'Cardiovascular Diseases', 'qualifier_ui': 'Q000517', 'qualifier_name': 'prevention & control', 'is_major_topic': True}, {'descriptor_ui': 'D016265', 'descriptor_name': 'Conflict of Interest', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D004345', 'descriptor_name': 'Drug Industry', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D019161', 'descriptor_name': 'Hydroxymethylglutaryl-CoA Reductase Inhibitors', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D006937', 'descriptor_name': 'Hypercholesterolemia', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D010820', 'descriptor_name': 'Physicians', 'qualifier_ui': 'Q000941', 'qualifier_name': 'ethics', 'is_major_topic': True}, {'descriptor_ui': 'D017410', 'descriptor_name': 'Practice Guidelines as Topic', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': True}, {'descriptor_ui': 'D002318', 'descriptor_name': 'Cardiovascular Diseases', 'qualifier_ui': 'Q000209', 'qualifier_name': 'etiology', 'is_major_topic': False}, {'descriptor_ui': 'D002318', 'descriptor_name': 'Cardiovascular Diseases', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D019161', 'descriptor_name': 'Hydroxymethylglutaryl-CoA Reductase Inhibitors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006937', 'descriptor_name': 'Hypercholesterolemia', 'qualifier_ui': 'Q000150', 'qualifier_name': 'complications', 'is_major_topic': False}, {'descriptor_ui': 'D006937', 'descriptor_name': 'Hypercholesterolemia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010820', 'descriptor_name': 'Physicians', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1136/bmj.f6989', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4393917726', 'display_name': 'BMJ', 'issn_l': '1756-1833', 'issn': ['1756-1833'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': None, 'host_organization_name': None, 'host_organization_lineage': [], 'host_organization_lineage_names': [], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/24264770', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 2, 'referenced_works': ['https://openalex.org/W1968128845', 'https://openalex.org/W2000988570'], 'related_works': ['https://openalex.org/W4389568370', 'https://openalex.org/W3108674512', 'https://openalex.org/W3032375762', 'https://openalex.org/W3031052312', 'https://openalex.org/W2748952813', 'https://openalex.org/W2586801360', 'https://openalex.org/W2080531066', 'https://openalex.org/W1995515455', 'https://openalex.org/W1506200166', 'https://openalex.org/W1489783725'], 'abstract_inverted_index': {'The': [0], 'chairman': [1], 'and': [2, 83, 125, 201, 203, 217], 'one': [3], 'of': [4, 8, 46, 58, 64, 149, 179], 'two': [5], 'additional': [6], 'co-chairs': [7], 'the': [9, 14, 29, 33, 40, 47, 61, 70, 88, 129, 146, 159, 177, 185], 'working': [10], 'panel': [11], 'that': [12, 161, 187, 235], 'wrote': [13, 139], 'controversial': [15], 'cholesterol': [16], 'guidelines': [17], 'on': [18, 165], 'reducing': [19], 'cardiovascular': [20], 'risk,': [21], 'released': [22], 'last': [23], 'week,1': [24], '2': [25], 'had': [26, 50, 114, 192, 205, 225], 'ties': [27, 94, 108, 122, 133, 164, 174, 194, 227], 'to': [28, 38, 86, 100, 115, 123, 128, 136, 184, 195, 210, 222, 230], 'drug': [30], 'industry': [31, 51, 97, 163], 'at': [32, 60, 145, 151], 'time': [34], 'they': [35], 'were': [36], 'asked': [37, 76], 'lead': [39], 'panel.': [41], 'And,': [42], 'in': [43, 109, 126, 154], 'all,': [44], 'eight': [45], '15': [48], 'panelists': [49], 'ties.\n\nThe': [52], 'chairman,': [53], 'Neil': [54], 'J': [55], 'Stone,': [56], 'professor': [57], 'medicine': [59], 'Feinberg': [62], 'School': [63, 148], 'Medicine,': [65], 'Northwestern': [66], 'University,': [67], 'Chicago,': [68], 'told': [69, 158], 'BMJ': [71, 160, 186], ',': [72], '“When': [73], 'I': [74, 91], 'was': [75, 175], 'by': [77], 'NHLBI': [78], '[the': [79], 'National': [80], 'Heart,': [81], 'Lung': [82], 'Blood': [84], 'Institute]': [85], 'chair': [87], '[cholesterol]': [89], 'panel,': [90], 'immediately': [92], 'severed': [93, 106], 'with': [95], 'all': [96], 'connections': [98], 'prior': [99], 'assuming': [101], 'my': [102], 'role': [103], 'as': [104, 207], 'chair.”\n\nHe': [105], 'those': [107], 'May': [110], '2008.': [111], 'Later': [112], 'he': [113, 138, 191, 204, 236], 'complete': [116], 'a': [117, 142, 208], 'disclosure': [118], 'statement': [119], 'regarding': [120, 131], 'financial': [121, 193, 226], 'industry,': [124], 'response': [127], 'question': [130], 'his': [132], 'from': [134], '2008': [135], '2012': [137], '“None.”\n\nDavid': [140], 'Newman,': [141], 'physician': [143], 'researcher': [144], 'Icahn': [147], 'Medicine': [150], 'Mt': [152], 'Sinai': [153], 'New': [155], 'York': [156], 'City,': [157], 'dropping': [162], 'taking': [166], 'up': [167], 'such': [168], 'roles': [169], 'without': [170], 'declaring': [171], 'these': [172], 'previous': [173], 'against': [176], 'spirit': [178], 'competing': [180], 'interests': [181], 'declarations.\n\nStone': [182], 'acknowledged': [183], 'before': [188], 'being': [189], 'empanelled': [190], 'Abbott,': [196, 211], 'AstraZeneca,': [197, 212], 'Merck,': [198, 213], 'Pfizer,': [199, 214], 'Sanofi-Aventis,': [200], 'Schering-Plough,': [202, 216], 'served': [206], 'consultant': [209], 'Reliant,': [215], 'Sonaste.': [218], 'All': [219], 'six': [220], 'corporations': [221], 'which': [223], 'Stone': [224, 233], 'make': [228], 'drugs': [229], 'treat': [231], 'hyperlipidemia.': [232], 'said': [234], '…': [237]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2079609061', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}, {'year': 2022, 'cited_by_count': 1}, {'year': 2020, 'cited_by_count': 2}, {'year': 2019, 'cited_by_count': 3}, {'year': 2017, 'cited_by_count': 4}, {'year': 2016, 'cited_by_count': 4}, {'year': 2015, 'cited_by_count': 13}, {'year': 2014, 'cited_by_count': 9}, {'year': 2013, 'cited_by_count': 1}], 'updated_date': '2024-12-17T04:33:26.896693', 'created_date': '2016-06-24'}